MSB 1.73% $1.18 mesoblast limited

Ann: Half Year Report and Accounts (including Appendix 4D), page-229

  1. 2,494 Posts.
    lightbulb Created with Sketch. 1518
    Unlike the other three expedited programs, the accelerated approval is a pathway. ... The difference is that drugs granted accelerated approval must promptly conduct post-marketing confirmatory trials to verify the clinical benefit (as early as underway at the time the marketing application is submitted


    Boy Dr Mcscientist, you are certainly broadening the focus.

    Maybe Msb will notify the market of funding for confirmatory trials which would be required for accelerated approval??

    Oh, that’s right, they just did that. I don’t like to answer nonholders but sometimes I just can’t help myself.

    You lot are like being at a football match and barracking against the vocal supporters. No club colours worn , no acknowledgment of great plays. When pressed on which club you support, you answer , oh me, I’m a tennis player, No idea about football.

    That was a non hangover analogy- I will endeavour to improve.

    Reg


 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.18
Change
0.020(1.73%)
Mkt cap ! $1.341B
Open High Low Value Volume
$1.20 $1.21 $1.17 $16.67M 14.04M

Buyers (Bids)

No. Vol. Price($)
5 54704 $1.18
 

Sellers (Offers)

Price($) Vol. No.
$1.18 10000 1
View Market Depth
Last trade - 16.10pm 07/05/2024 (20 minute delay) ?
Last
$1.19
  Change
0.020 ( 3.40 %)
Open High Low Volume
$1.21 $1.21 $1.17 2927691
Last updated 15.59pm 07/05/2024 ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.